1.0ONE-TWENTY TWO: Trading Financial Marketshttps://drduru.com/onetwentytwoDr. Duruhttps://drduru.com/onetwentytwo/author/admin/rich600338<blockquote class="wp-embedded-content" data-secret="gpOqRJO7lR"><a href="https://drduru.com/onetwentytwo/2017/10/05/dexcom-danger-and-opportunity/">The Danger in DexCom…and the Opportunity</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://drduru.com/onetwentytwo/2017/10/05/dexcom-danger-and-opportunity/embed/#?secret=gpOqRJO7lR" width="600" height="338" title="“The Danger in DexCom…and the Opportunity” — ONE-TWENTY TWO: Trading Financial Markets" data-secret="gpOqRJO7lR" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript"> /* <![CDATA[ */ /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://drduru.com/onetwentytwo/wp-includes/js/wp-embed.min.js /* ]]> */ </script> DexCom (DXCM) is a maker of continuous glucose monitoring (CGM) systems. Last week, the stock of the company cratered after Abbott Laboratories (ABT) received FDA approval of its competing FreeStyle Libre flash CGM. It is the first system that allows diabetics to check and monitor glucose levels without sticking themselves. In response to the news, ... Read morehttp://drduru.com/onetwentytwo/wp-content/uploads/2017/10/171005_DXCM.jpg